{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:50:52Z","timestamp":1791575452229,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41418-020-0568-2","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T14:33:38Z","timestamp":1591194818000},"page":"3131-3145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["USP22 positively modulates ER\u03b1 action via its deubiquitinase activity in breast cancer"],"prefix":"10.1038","volume":"27","author":[{"given":"Shengli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renlong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8983-0024","authenticated-orcid":false,"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"key":"568_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2011-1057","volume":"34","author":"B Manavathi","year":"2013","unstructured":"Manavathi B, Dey O, Gajulapalli VNR, Bhatia RS, Bugide S, Kumar R. Derailed estrogen signaling and breast cancer: an authentic couple. Endocr Rev. 2013;34:1\u201332.","journal-title":"Endocr Rev"},{"key":"568_CR2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrc721","volume":"2","author":"S Ali","year":"2002","unstructured":"Ali S, Coombes RC. Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer. 2002;2:101\u201312.","journal-title":"Nat Rev Cancer"},{"key":"568_CR3","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.1422015112","volume":"112","author":"J Yang","year":"2015","unstructured":"Yang J, AlTahan A, Jones DT, Buffa FM, Bridges E, Interiano RB, et al. Estrogen receptor-alpha directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer. Proc Natl Acad Sci USA. 2015;112:15172\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"568_CR4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.molcel.2017.02.008","volume":"65","author":"JD Stender","year":"2017","unstructured":"Stender JD, Nwachukwu JC, Kastrati I, Kim Y, Strid T, Yakir M, et al. Structural and molecular mechanisms of cytokine-mediated endocrine resistance in human breast cancer cells. Mol cell. 2017;65:1122\u201335.e1125.","journal-title":"Mol cell"},{"key":"568_CR5","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1038\/onc.2016.105","volume":"35","author":"S Bhatt","year":"2016","unstructured":"Bhatt S, Stender JD, Joshi S, Wu G, Katzenellenbogen BS. OCT-4: a novel estrogen receptor-alpha collaborator that promotes tamoxifen resistance in breast cancer cells. Oncogene. 2016;35:5722\u201334.","journal-title":"Oncogene"},{"key":"568_CR6","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.drudis.2016.05.012","volume":"21","author":"T De Marchi","year":"2016","unstructured":"De Marchi T, Foekens JA, Umar A, Martens JWM. Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer. Drug Discov Today. 2016;21:1181\u20138.","journal-title":"Drug Discov Today"},{"key":"568_CR7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1210\/er.2010-0016","volume":"32","author":"M Le Romancer","year":"2011","unstructured":"Le Romancer M, Poulard C, Cohen P, Sentis S, Renoir JM, Corbo L. Cracking the estrogen receptor\u2019s posttranslational code in breast tumors. Endocr Rev. 2011;32:597\u2013622.","journal-title":"Endocr Rev"},{"key":"568_CR8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0092-8674(03)00234-4","volume":"113","author":"N Fujita","year":"2003","unstructured":"Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA. MTA3, a Mi-2\/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell. 2003;113:207\u201319.","journal-title":"Cell"},{"key":"568_CR9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrc3622","volume":"14","author":"W Zhou","year":"2014","unstructured":"Zhou W, Slingerland JM. Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy. Nat Rev Cancer. 2014;14:26\u201338.","journal-title":"Nat Rev Cancer"},{"key":"568_CR10","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1158\/2159-8290.CD-15-0090","volume":"5","author":"K Jin","year":"2015","unstructured":"Jin K, Park S, Teo WW, Korangath P, Cho SS, Yoshida T, et al. HOXB7 Is an ERalpha cofactor in the activation of HER2 and Multiple ER target genes leading to endocrine resistance. Cancer Discov. 2015;5:944\u201359.","journal-title":"Cancer Discov"},{"key":"568_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.730","volume":"43","author":"A Hurtado","year":"2011","unstructured":"Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet. 2011;43:27\u201333.","journal-title":"Nat Genet"},{"key":"568_CR12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/nar\/gku1298","volume":"43","author":"MA Wade","year":"2015","unstructured":"Wade MA, Jones D, Wilson L, Stockley J, Coffey K, Robson CN, et al. The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer. Nucleic Acids Res. 2015;43:196\u2013207.","journal-title":"Nucleic Acids Res"},{"key":"568_CR13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.molcel.2018.03.006","volume":"70","author":"WW Gao","year":"2018","unstructured":"Gao WW, Xiao RQ, Zhang WJ, Hu YR, Peng BL, Li WJ, et al. JMJD6 licenses ERalpha-dependent enhancer and coding gene activation by modulating the recruitment of the CARM1\/MED12 co-activator complex. Mol Cell. 2018;70:340\u201357.e348.","journal-title":"Mol Cell"},{"key":"568_CR14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.molcel.2007.12.011","volume":"29","author":"Y Zhao","year":"2008","unstructured":"Zhao Y, Lang G, Ito S, Bonnet J, Metzger E, Sawatsubashi S, et al. A TFTC\/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. Mol Cell. 2008;29:92\u2013101.","journal-title":"Mol Cell"},{"key":"568_CR15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.molcel.2009.06.015","volume":"35","author":"BS Atanassov","year":"2009","unstructured":"Atanassov BS, Evrard YA, Multani AS, Zhang Z, Tora L, Devys D, et al. Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance. Mol Cell. 2009;35:352\u201364.","journal-title":"Mol Cell"},{"key":"568_CR16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.molcel.2012.03.024","volume":"46","author":"Z Lin","year":"2012","unstructured":"Lin Z, Yang H, Kong Q, Li J, Lee SM, Gao B, et al. USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development. Mol Cell. 2012;46:484\u201394.","journal-title":"Mol Cell"},{"key":"568_CR17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/embor.2011.140","volume":"12","author":"BS Atanassov","year":"2011","unstructured":"Atanassov BS, Dent SY. USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1. EMBO Rep. 2011;12:924\u201330.","journal-title":"EMBO Rep"},{"key":"568_CR18","doi-asserted-by":"crossref","first-page":"E9298","DOI":"10.1073\/pnas.1807704115","volume":"115","author":"VJ Gennaro","year":"2018","unstructured":"Gennaro VJ, Stanek TJ, Peck AR, Sun Y, Wang F, Qie S, et al. Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells. Proc Natl Acad Sci USA. 2018;115:E9298\u2013307.","journal-title":"Proc Natl Acad Sci USA"},{"key":"568_CR19","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI23412","volume":"115","author":"GV Glinsky","year":"2005","unstructured":"Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Investig. 2005;115:1503\u201321.","journal-title":"J Clin Investig"},{"key":"568_CR20","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.4161\/cc.5.11.2796","volume":"5","author":"GV Glinsky","year":"2006","unstructured":"Glinsky GV. Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway. Cell Cycle. 2006;5:1208\u201316.","journal-title":"Cell Cycle"},{"key":"568_CR21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/PDM.0b013e3181e202f2","volume":"19","author":"Y Liu","year":"2010","unstructured":"Liu Y, Yang Y, Xu H, Dong X. Implication of USP22 in the regulation of BMI-1, c-Myc, p16INK4a, p14ARF, and cyclin D2 expression in primary colorectal carcinomas. Diagnostic Mol Pathol. 2010;19:194\u2013200.","journal-title":"Diagnostic Mol Pathol"},{"key":"568_CR22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-010-0585-4","volume":"346","author":"L Lv","year":"2011","unstructured":"Lv L, Xiao XY, Gu ZH, Zeng FQ, Huang LQ, Jiang GS. Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells. Mol Cell Biochem. 2011;346:11\u201321.","journal-title":"Mol Cell Biochem"},{"key":"568_CR23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s12013-011-9229-x","volume":"61","author":"DD Yang","year":"2011","unstructured":"Yang DD, Cui BB, Sun LY, Zheng HQ, Huang Q, Tong JX, et al. The co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinoma. Cell Biochem Biophys. 2011;61:703\u201310.","journal-title":"Cell Biochem Biophys"},{"key":"568_CR24","doi-asserted-by":"crossref","first-page":"e42540","DOI":"10.1371\/journal.pone.0042540","volume":"7","author":"S Piao","year":"2012","unstructured":"Piao S, Liu Y, Hu J, Guo F, Ma J, Sun Y, et al. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma. PLoS ONE. 2012;7:e42540.","journal-title":"PLoS ONE"},{"key":"568_CR25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1158\/0008-5472.CAN-13-1954","volume":"74","author":"RS Schrecengost","year":"2014","unstructured":"Schrecengost RS, Dean JL, Goodwin JF, Schiewer MJ, Urban MW, Stanek TJ, et al. USP22 regulates oncogenic signaling pathways to drive lethal cancer progression. Cancer Res. 2014;74:272\u201386.","journal-title":"Cancer Res"},{"key":"568_CR26","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3892\/ijo.2014.2531","volume":"45","author":"Z Ning","year":"2014","unstructured":"Ning Z, Wang A, Liang J, Xie Y, Liu J, Feng L, et al. USP22 promotes the G1\/S phase transition by upregulating FoxM1 expression via beta-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma. Int J Oncol. 2014;45:1594\u2013608.","journal-title":"Int J Oncol"},{"key":"568_CR27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbrc.2015.03.093","volume":"460","author":"H Xiao","year":"2015","unstructured":"Xiao H, Tian Y, Yang Y, Hu F, Xie X, Mei J, et al. USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer. Biochem biophys Res Commun. 2015;460:703\u20138.","journal-title":"Biochem biophys Res Commun"},{"key":"568_CR28","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3892\/ijo.2015.3214","volume":"47","author":"B Tang","year":"2015","unstructured":"Tang B, Liang X, Tang F, Zhang J, Zeng S, Jin S, et al. Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma. Int J Oncol. 2015;47:2208\u201316.","journal-title":"Int J Oncol"},{"key":"568_CR29","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00432-011-0998-9","volume":"137","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Yao L, Zhang X, Ji H, Wang L, Sun S, et al. Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer. J Cancer Res Clin Oncol. 2011;137:1245\u201353.","journal-title":"J Cancer Res Clin Oncol"},{"key":"568_CR30","doi-asserted-by":"crossref","first-page":"12654","DOI":"10.18632\/oncotarget.3705","volume":"6","author":"B Tang","year":"2015","unstructured":"Tang B, Tang F, Li B, Yuan S, Xu Q, Tomlinson S, et al. High USP22 expression indicates poor prognosis in hepatocellular carcinoma. Oncotarget. 2015;6:12654\u201367.","journal-title":"Oncotarget"},{"key":"568_CR31","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s13277-013-0696-0","volume":"34","author":"H Wang","year":"2013","unstructured":"Wang H, Li YP, Chen JH, Yuan SF, Wang L, Zhang JL, et al. Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma. Tumour Biol. 2013;34:1635\u20139.","journal-title":"Tumour Biol"},{"key":"568_CR32","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.57","volume":"5","author":"M Kongsema","year":"2016","unstructured":"Kongsema M, Zona S, Karunarathna U, Cabrera E, Man EP, Yao S, et al. RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment. Oncogenesis. 2016;5:e252.","journal-title":"Oncogenesis"},{"key":"568_CR33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccr.2009.02.021","volume":"15","author":"K Xu","year":"2009","unstructured":"Xu K, Shimelis H, Linn DE, Jiang R, Yang X, Sun F, et al. Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell. 2009;15:270\u201382.","journal-title":"Cancer Cell"},{"key":"568_CR34","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1158\/0008-5472.CAN-07-0967","volume":"67","author":"V Duong","year":"2007","unstructured":"Duong V, Boulle N, Daujat S, Chauvet J, Bonnet S, Neel H, et al. Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents. Cancer Res. 2007;67:5513\u201321.","journal-title":"Cancer Res"},{"key":"568_CR35","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/nm.2536","volume":"17","author":"P D\u2019Arcy","year":"2011","unstructured":"D\u2019Arcy P, Brnjic S, Olofsson MH, Fryknas M, Lindsten K, De Cesare M, et al. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat Med. 2011;17:1636\u201340.","journal-title":"Nat Med"},{"key":"568_CR36","first-page":"141","volume":"62","author":"S Fan","year":"2002","unstructured":"Fan S, Ma YX, Wang C, Yuan R-Q, Meng Q, Wang J-A, et al. p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res. 2002;62:141\u201351.","journal-title":"Cancer Res"},{"key":"568_CR37","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1210\/me.2005-0111","volume":"19","author":"M Fan","year":"2005","unstructured":"Fan M, Park A, Nephew KP. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha. Mol Endocrinol. 2005;19:2901\u201314.","journal-title":"Mol Endocrinol"},{"key":"568_CR38","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature07960","volume":"458","author":"D Hoeller","year":"2009","unstructured":"Hoeller D, Dikic I. Targeting the ubiquitin system in cancer therapy. Nature. 2009;458:438\u201344.","journal-title":"Nature"},{"key":"568_CR39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1172\/JCI71602","volume":"124","author":"NM Weathington","year":"2014","unstructured":"Weathington NM, Mallampalli RK. Emerging therapies targeting the ubiquitin proteasome system in cancer. J Clin Investig. 2014;124:6\u201312.","journal-title":"J Clin Investig"},{"key":"568_CR40","volume":"7","author":"X Xia","year":"2018","unstructured":"Xia X, Liao Y, Guo Z, Li Y, Jiang L, Zhang F, et al. Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer. Oncogenesis. 2018;7:75.","journal-title":"Oncogenesis"},{"key":"568_CR41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","volume":"22","author":"D Chauhan","year":"2012","unstructured":"Chauhan D, Tian Z, Nicholson B, Kumar KGS, Zhou B, Carrasco R, et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell. 2012;22:345\u201358.","journal-title":"Cancer Cell"},{"key":"568_CR42","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1158\/0008-5472.CAN-10-1530","volume":"70","author":"V Kapuria","year":"2010","unstructured":"Kapuria V, Peterson LF, Fang D, Bornmann WG, Talpaz M, Donato NJ. Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis. Cancer Res. 2010;70:9265\u201376.","journal-title":"Cancer Res"},{"key":"568_CR43","doi-asserted-by":"crossref","first-page":"992","DOI":"10.7150\/ijbs.10918","volume":"11","author":"R Zou","year":"2015","unstructured":"Zou R, Zhong X, Wang C, Sun H, Wang S, Lin L, et al. MDC1 enhances estrogen receptor-mediated transactivation and contributes to breast cancer suppression. Int J Biol Sci. 2015;11:992\u20131005.","journal-title":"Int J Biol Sci"},{"key":"568_CR44","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1093\/nar\/gkv394","volume":"43","author":"C Wang","year":"2015","unstructured":"Wang C, Sun H, Zou R, Zhou T, Wang S, Sun S, et al. MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer. Nucleic Acids Res. 2015;43:4893\u2013908.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41418-020-0568-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41418-020-0568-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41418-020-0568-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:15:59Z","timestamp":1684617359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-0568-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1038\/s41418-020-0568-2","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"30 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}